Australia, May 19 -- ACADIA Pharmaceuticals Inc., owns the trademark (2626903) for 'DAYBUE STIX' till Jan. 8, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and prevention of neurologic, genetic, psychologic, and psychiatric diseases and disorders.], 35 [Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals.] and 44 [Consultancy in the field of the medical treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome; consultancy in the field of the medical diagnosis of neurologic, genetic, psychologic, and p...